
| Applicant | Tradename | Generic Name | NDA | Approval Date | Type | RLD | Patent Number | Product | Substance | Delist Req. | Patent Expiration | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim | MIRAPEX ER | pramipexole dihydrochloride | 022421 | Feb 19, 2010 | RX | Yes | 7,695,734 | Y | Apr 26, 2028 | |||
| Boehringer Ingelheim | MIRAPEX ER | pramipexole dihydrochloride | 022421 | Feb 19, 2010 | RX | No | 7,695,734 | Y | Apr 26, 2028 | |||
| Questcor Pharms | DORAL | quazepam | 018708 | Feb 26, 1987 | DISCN | No | 7,608,616 | Jun 3, 2028 | METHOD FOR TREATING INSOMNIA WHILE REDUCING THE RISK OF AN ADVERSE DRUG INTERACTION |
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright © 2000-2010, thinkBiotech LLC.